Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 5 October 1973:
Vol. 182. no. 4107, pp. 62 - 64
DOI: 10.1126/science.182.4107.62
Prev | Table of Contents | Next

Articles

Peroxisomal and Mitochondrial Defects in the Cerebro-Hepato-Renal Syndrome

Sidney Goldfischer 1, Cyril L. Moore 1, Anne B. Johnson 1, Alfred J. Spiro 1, Marius P. Valsamis 1, Henry K. Wisniewski 1, Robert H. Ritch 1, William T. Norton 1, Isabelle Rapin 1, and Lawrence M. Gartner 1

1 Departments of Pathology, Neurology, and Pediatrics, and Rose F. Kennedy Center for Research in Mental Retardation and Human Development, Albert Einstein College of Medicine, Bronx, New York 10461

The cerebro-hepato-renal syndrome is a rare familial malady with cerebral, renal, and skeletal abnormalities, severe hypotonia, cirrhosis, iron and lipid storage, and death within 6 months. Correlated electron microscopic, histochemical, and biochemical studies demonstrate defects in two oxidative organelles. Peroxisomes cannot be found in hepatocytes and renal proximal tubules. In hepatocytes and cortical astrocytes, mitochondria are distorted in their appearance and glycogen stores are increased. Oxygen consumnption of brain and liver mitochondrial preparations with succinate and with substrates reducing nicotinamide adenine dinucleotide is markedly diminished, but the consumption is normal with ascorbate and tetramethylphenylenediamine, which suggests a defect in electron transport prior to the cytochromes. Histochemical studies of mitochondrial oxidation point to a defect between the succinate dehydrogenase flavoprotein and coenzyme Q, possibly in the region of nonheme iron protein.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Identification of a novel PEX14 mutation in Zellweger syndrome.
S. J Huybrechts, P. P Van Veldhoven, I. Hoffman, R. Zeevaert, R. de Vos, P. Demaerel, M. Brams, J. Jaeken, M. Fransen, and D. Cassiman (2009)
BMJ Case Reports 2009, bcr0720080503
   Abstract »    Full Text »
Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture.
S. Hein, P. Schonfeld, S. Kahlert, and G. Reiser (2008)
Hum. Mol. Genet. 17, 1750-1761
   Abstract »    Full Text »    PDF »
Identification of a novel PEX14 mutation in Zellweger syndrome.
S J Huybrechts, P P Van Veldhoven, I Hoffman, R Zeevaert, R de Vos, P Demaerel, M Brams, J Jaeken, M Fransen, and D Cassiman (2008)
J. Med. Genet. 45, 376-383
   Abstract »    Full Text »    PDF »
Neuroimaging of peroxisome biogenesis disorders (Zellweger spectrum) with prolonged survival.
P. G. Barth, C. B.L.M. Majoie, J. Gootjes, R. J.A. Wanders, H. R. Waterham, M. S. van der Knaap, J. B.C. de Klerk, J. Smeitink, and B. T. Poll-The (2004)
Neurology 62, 439-444
   Abstract »    Full Text »    PDF »
Overexpression of Peroxisome Proliferator-activated Receptor-{alpha} (PPAR{alpha})-regulated Genes in Liver in the Absence of Peroxisome Proliferation in Mice Deficient in both L- and D-Forms of Enoyl-CoA Hydratase/Dehydrogenase Enzymes of Peroxisomal {beta}-Oxidation System.
Y. Jia, C. Qi, Z. Zhang, T. Hashimoto, M. S. Rao, S. Huyghe, Y. Suzuki, P. P. Van Veldhoven, M. Baes, and J. K. Reddy (2003)
J. Biol. Chem. 278, 47232-47239
   Abstract »    Full Text »    PDF »
Pex13 Inactivation in the Mouse Disrupts Peroxisome Biogenesis and Leads to a Zellweger Syndrome Phenotype.
M. Maxwell, J. Bjorkman, T. Nguyen, P. Sharp, J. Finnie, C. Paterson, I. Tonks, B. C. Paton, G. F. Kay, and D. I. Crane (2003)
Mol. Cell. Biol. 23, 5947-5957
   Abstract »    Full Text »    PDF »
Role of ALDP (ABCD1) and Mitochondria in X-Linked Adrenoleukodystrophy.
M. C. McGuinness, J.-F. Lu, H.-P. Zhang, G.-X. Dong, A. K. Heinzer, P. A. Watkins, J. Powers, and K. D. Smith (2003)
Mol. Cell. Biol. 23, 744-753
   Abstract »    Full Text »    PDF »
PEX11{beta} Deficiency Is Lethal and Impairs Neuronal Migration but Does Not Abrogate Peroxisome Function.
X. Li, E. Baumgart, J. C. Morrell, G. Jimenez-Sanchez, D. Valle, and S. J. Gould (2002)
Mol. Cell. Biol. 22, 4358-4365
   Abstract »    Full Text »    PDF »
Tubulo-Reticular Clusters of Peroxisomes in Living COS-7 Cells: Dynamic Behavior and Association with Lipid Droplets.
M. Schrader (2001)
J. Histochem. Cytochem. 49, 1421-1430
   Abstract »    Full Text »    PDF »
Building New Models for Peroxisome Biogenesis.
T. L. Johnson and L. J. Olsen (2001)
Plant Physiology 127, 731-739
   Full Text »    PDF »
Mitochondrial Alterations Caused by Defective Peroxisomal Biogenesis in a Mouse Model for Zellweger Syndrome (PEX5 Knockout Mouse).
E. Baumgart, I. Vanhorebeek, M. Grabenbauer, M. Borgers, P. E. Declercq, H. D. Fahimi, and M. Baes (2001)
Am. J. Pathol. 159, 1477-1494
   Abstract »    Full Text »
Evidence for a novel pathway for the targeting of a Saccharomyces cerevisiae peroxisomal protein belonging to the isomerase/hydratase family.
I. Karpichev and G. Small (2000)
J. Cell Sci. 113, 533-544
   Abstract »    PDF »
Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders1.
M. Martinez, E. Vazquez, M T. Garcia-Silva, J. Manzanares, J. M Bertran, F. Castello, and I. Mougan (2000)
Am. J. Clinical Nutrition 71, 376S-385S
   Abstract »    Full Text »    PDF »
Current Cytochemical Techniques for the Investigation of Peroxisomes: A Review.
H. D. Fahimi and E. Baumgart (1999)
J. Histochem. Cytochem. 47, 1219-1232
   Abstract »    Full Text »
Picture of the Month.
J. R. Dana and W. W. Tunnessen Jr (1999)
Arch Pediatr Adolesc Med 153, 1105-1106
   Full Text »    PDF »
Peroxisomal Disease-Common Ground for Pediatrician, Cell Biologist, Biochemist, Pathologist, and Neurologist.
K. S. Roth (1999)
Clinical Pediatrics 38, 73-75
   PDF »
Zeliweger Syndrome in Saudi Arabia and Its Distinct Features.
M. Al-Essa, G. S. Dhaunsi, M. Rashed, P. T. Ozand, and Z. Rahbeeni (1999)
Clinical Pediatrics 38, 77-86
   Abstract »    PDF »
Metabolic control of peroxisome abundance.
C. Chang, S South, D Warren, J Jones, A. Moser, H. Moser, and S. Gould (1999)
J. Cell Sci. 112, 1579-1590
   Abstract »    PDF »
Fish oil and myelin: Cautious optimism for treatment of children with disorders of peroxisome biogenesis.
M. J. Noetzel (1998)
Neurology 51, 5-7
   Full Text »    PDF »
MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders.
M. Martinez and E. Vazquez (1998)
Neurology 51, 26-32
   Abstract »    Full Text »    PDF »
Alkyl-Dihydroxyacetonephosphate Synthase. FATE IN PEROXISOME BIOGENESIS DISORDERS AND IDENTIFICATION OF THE POINT MUTATION UNDERLYING A SINGLE ENZYME DEFICIENCY.
E. C. J. M. de Vet, L. IJlst, W. Oostheim, R. J. A. Wanders, and H. van den Bosch (1998)
J. Biol. Chem. 273, 10296-10301
   Abstract »    Full Text »    PDF »
Components Involved in Peroxisome Import, Biogenesis, Proliferation, Turnover, and Movement.
S. SUBRAMANI (1998)
Physiol Rev 78, 171-188
   Abstract »    Full Text »    PDF »
Targeted Deletion of the PEX2 Peroxisome Assembly Gene in Mice Provides a Model for Zellweger Syndrome, a Human Neuronal Migration Disorder.
P. L. Faust and M. E. Hatten (1997)
J. Cell Biol. 139, 1293-1305
   Abstract »    Full Text »    PDF »
Hepatocellular and Hepatic Peroxisomal Alterations in Mice with a Disrupted Peroxisomal Fatty Acyl-coenzyme A Oxidase Gene.
C.-Y. Fan, J. Pan, R. Chu, D. Lee, K. D. Kluckman, N. Usuda, I. Singh, A. V. Yeldandi, M. S. Rao, N. Maeda, et al. (1996)
J. Biol. Chem. 271, 24698-24710
   Abstract »    Full Text »    PDF »
Microtubule-based peroxisome movement.
S Rapp, R Saffrich, M Anton, U Jakle, W Ansorge, K Gorgas, and W. Just (1996)
J. Cell Sci. 109, 837-849
   Abstract »    PDF »
Novel Peroxisomal Populations in Subcellular Fractions from Rat Liver.
M. Wilcke, K. Hultenby, and S. E. H. Alexson (1995)
J. Biol. Chem. 270, 6949-6958
   Abstract »    Full Text »    PDF »
Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders.
M. Slawecki, G Dodt, S Steinberg, A. Moser, H. Moser, and S. Gould (1995)
J. Cell Sci. 108, 1817-1829
   Abstract »    PDF »
X-Linked Dominant Ichthyosis With Peroxisomal Deficiency: An Ultrastructural and Ultracytochemical Study of the Conradi-Hunermann Syndrome and Its Murine Homologue, the Bare Patches Mouse.
S. Emami, K. P. Hanley, N. B. Esterly, N. Daniallinia, and M. L. Williams (1994)
Arch Dermatol 130, 325-336
   Abstract »    PDF »
Peroxisomal Disorders: Neurodevelopmental and Biochemical Aspects.
F. R. Brown III, R. Voigt, A. K. Singh, and I. Singh (1993)
Arch Pediatr Adolesc Med 147, 617-626
   Abstract »    PDF »
A human gene responsible for Zellweger syndrome that affects peroxisome assembly.
N Shimozawa, T Tsukamoto, Y Suzuki, T Orii, Y Shirayoshi, T Mori, and Y Fujiki (1992)
Science 255, 1132-1134
   Abstract »    PDF »
Peroxisomal membrane ghosts in Zellweger syndrome--aberrant organelle assembly.
M. Santos, T Imanaka, H Shio, G. Small, and P. Lazarow (1988)
Science 239, 1536-1538
   Abstract »    PDF »
Peroxisomal Disorders: A Review of a Recently Recognized Group of Clinical Entities.
D. Talwar and K. F. Swaiman (1987)
Clinical Pediatrics 26, 497-504
   Abstract »    PDF »
Peroxisomal defects in neonatal-onset and X-linked adrenoleukodystrophies.
S Goldfischer, J Collins, I Rapin, B Coltoff-Schiller, C. Chang, M Nigro, V. Black, N. Javitt, H. Moser, and P. Lazarow (1985)
Science 227, 67-70
   Abstract »    PDF »
Mitochondrial Defects in Lowe's Oculocerebrorenal Syndrome.
J. M. Gobernado, M. Lousa, A. Gimeno, and M. Gonsalvez (1984)
Arch Neurol 41, 208-209
   Abstract »    PDF »
Hyperpipecolic Acidemia: Occurrence in an Infant With Clinical Findings of the Cerebrohepatorenal (Zellweger) Syndrome.
D. W. Arneson, R. E. Tipton, and J. C. Ward (1982)
Arch Neurol 39, 713-716
   Abstract »    PDF »
Zellweger Syndrome: Lenticular Opacities Indicating Carrier Status and Lens Abnormalities Characteristic of Homozygotes.
H. M. Hittner, F. L. Kretzer, and R. S. Mehta (1981)
Arch Ophthalmol 99, 1977-1982
   Abstract »    PDF »
Defects of bile acid synthesis in Zellweger's syndrome.
R. Hanson, P Szczepanik-VanLeeuwen, G. Williams, G Grabowski, and H. Sharp (1979)
Science 203, 1107-1108
   Abstract »    PDF »
And Now--Dysoxia.
Z. Danilevicius (1977)
JAMA 238, 1056
   Abstract »    PDF »
Dysoxia: Abnormal Tissue Oxygen Utilization.
E. D. Robin (1977)
Arch Intern Med 137, 905-910
   Abstract »    PDF »
Familial Poliodystrophy, Mitochondrial Myopathy, and Lactate Acidemia.
Z. H. Hart, C.-H. Chang, E. V. D. Perrin, J. S. Neerunjun, and R. Ayyar (1977)
Arch Neurol 34, 180-185
   Abstract »    PDF »
Peroxisomal Straight-chain Acyl-CoA Oxidase and D-bifunctional Protein Are Essential for the Retroconversion Step in Docosahexaenoic Acid Synthesis.
H.-M. Su, A. B. Moser, H. W. Moser, and P. A. Watkins (2001)
J. Biol. Chem. 276, 38115-38120
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)